REQUEST A DEMO
Total
USD $0.00
Search more companies

R&G Pharmastudies Co.,Ltd (诺思格(北京)医药科技股份有限公司) (China)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: R&G Pharmastudies Co.,Ltd Profile Updated: March 29, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

R&G Pharmastudies Co.,Ltd (诺思格(北京)医药科技股份有限公司) is a company in China, with a head office in Beijing. It operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. It was incorporated on August 22, 2008. It currently has a total number of 2,208 (2024) employees. From the latest financial highlights, R&G Pharmastudies Co.,Ltd (诺思格(北京)医药科技股份有限公司) reported a net sales revenue increase of 14.38% in 2025. Its total assets grew by 2.71% over the same period. The enterprise’s net profit margin decreased by 2.81% in 2025.

Headquarters
11th Floor, North Tower, Block B, Huatong Building, No. 19 Chegongzhuang West Road, Haidian District, Beijing
Beijing; Beijing; Postal Code: 100048

Contact Details: Purchase the R&G Pharmastudies Co.,Ltd (诺思格(北京)医药科技股份有限公司) report to view the information.

Website: http://www.rg-pharma.com

Basic Information
Total Employees:
Purchase the R&G Pharmastudies Co.,Ltd (诺思格(北京)医药科技股份有限公司) report to view the information.
Outstanding Shares:
Purchase the R&G Pharmastudies Co.,Ltd (诺思格(北京)医药科技股份有限公司) report to view the information.
Registered Capital:
Purchase the R&G Pharmastudies Co.,Ltd (诺思格(北京)医药科技股份有限公司) report to view the information.
Financial Auditors:
Purchase the R&G Pharmastudies Co.,Ltd (诺思格(北京)医药科技股份有限公司) report to view the information.
Incorporation Date:
August 22, 2008
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
28.51%
Purchase this report to view the information.
12.15%
Purchase this report to view the information.
11.93%
Purchase this report to view the information.
7.08%
Purchase this report to view the information.
3.45%
Subsidiaries
Beijing Nuohe Management Consulting Co., Ltd
100%
Hefei Ecoman Medical Technology Co., Ltd.
100%
Nanjing Aikeman Information Technology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after R&G Pharmastudies Co.,Ltd (诺思格(北京)医药科技股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
14.38%
Total Operating Revenue
13.41%
Operating Profit
-1.7%
Net Profit/Loss for the Period
-2.47%
Total Assets
2.71%
Total Equity
7.6%
Operating Profit Margin
-2.99%
Net Profit Margin
-2.81%
Return on Equity (ROE)
-0.72%
Quick Ratio
709.25%
Cash Ratio
0.48%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?